Head of Human and Comparative Genomics Laboratory in the Biodesign Institute at Arizona State University. Affiliated faculty with the Center for Evolution and Medicine, ASU.
My research is at the interface of genetics, statistics, and software development. I am primarily interested in developing statistical models to estimate evolutionary process from large, genomic datasets. Currently most of my research is connected to mutations.
Current research is focused on testing & design-for-testability of integrated circuits; digital microfluidics, biochips, & cyberphysical systems; optimization of digital print and production system infrastructure. Currently an ACM Distinguished Speaker & has been a Distinguished Visitor of the IEEE Computer Society. Recipient of many awards, including the Humboldt Research Award. Editor-in-Chief of ACM Journal on Emerging Technologies in Computing Systems and IEEE Transactions on VLSI Systems.
Assistant Professor of Biostatistics, Mayo Clinic. Ph.D., University of Pennsylvania. My research concerns the development and application of powerful and robust statistical methods for high-dimensional "omics" data, arising from modern high-throughput technologies such as microarray and next-generation sequencing. I am particularly interested in methods for microbiome sequencing data. Much of this effort is motivated by ongoing collaborations in projects that study the role of the human microbiome in disease pathogenesis using metagenomic sequencing.
Research interests include statistical genetics, genomics and metagenomics; and high-dimensional statistics.
Minjun Chen is a principal investigator working at the Division of Bioinformatics and Biostatics of the US FDA’s National Center for Toxicological Research and serve as the adjunct faculty and mentor for the bioinformatics program joint by Univ. of Arkansas at Little Rock (UALR) and Univ. of Arkansas for Medical Sciences (UAMS). Currently, he co-chairs the FDA Liver Toxicity Working Group since 2014 and is the editor of the Springer book titled “Drug-induced Liver Toxicity”. His primary research interests encompass drug-induced liver injury, drug safety, bioinformatics, and personalized medicine. He has authored or co-authored more than 80 scientific publications and book chapters.
Constance Ciaudo has been Assistant Professor of RNAi and Genome Integrity at the Institute of Molecular Health Science at ETH Zurich since April 2013. She obtained her PhD degree in 2006 at the Pasteur Institute in Paris, France After four years as a postdoctoral fellow at the Curie Institute in Paris, supervised by Prof. Edith Heard and at the Institute of Plant Biology (IBMP) in Strasbourg, France, supervised by Prof. Olivier Voinnet, she worked from 2010-2013 at ETH Zurich, Switzerland.
Graduated from Oxford University in physics and proceeded to a physics PhD at Manchester University. Saw the light and came over to biology through protein structure prediction into genome annotation. Founded the Ensembl database alongside Ewan Birney and Tim Hubbard at the Sanger Institute. Crossed the pond to the Broad Institute where many mammals were sequenced and the human gene count trimmed of its fat. Had a short enjoyable interlude in the commercial sphere at Bioteam and is now residing at Harvard University with fingers in many pies.
Molecular biologist at the Division of Genetic Epidemiology of the Medical University of Innsbruck. Lab head of the Sequencing and Genotyping Core Facility.
Major research focuses are the genetics of complex diseases with a special focus on lipid- and atherosclerosis related traits, next generation sequencing, the genetics of Lipoprotein(a), third generation sequencing and applied bioinformatics.
Full Professor and former Chair of the Department of Biological Sciences at Florida International University. Director of FIU DNA Core facility. Past Program Director for NSF Division of Environmental Biology, Systematics and Biodiversity Cluster.
Research interests include: Molecular Systematics, Evolution, Biogeography, and Phylogeography: Rates, patterns, and mechanisms of molecular evolution , including nucleotide sequence evolution and mitochondrial gene order change, and consequences for phylogenetic reconstruction and reconstruction of ancestral states. Integration of molecular data with paleontological and morphological data. Using phylogenies to address biological questions.
Senior Lecturer in Biological Sciences at the University of Huddersfield, since 2015. Previously Junior Research Fellow, College Lecturer In Biochemistry and various postdocs at the University of Oxford (2013-15). Working on DNA replication, genome integrity and transcription factors in human cancers (and also in prokaryotes). Additional interests in phylogenomics and novel protein expression systems.
Founding Director of the Computational Biology Institute at George Washington University. Past Chair of the Department of Biology at Brigham Young University. PhD in Biology and Biomedical Sciences from Washington University in St. Louis.
Professor of Biology and Associate Vice President for Research at the University of Oregon. Research focuses on the genetics and genomics of evolutionary change. Elected Fellow, AAAS.
Xiangqin Cui is an associate professor in the Biostatistics Department, Section on Statistical Genetics, at University of Alabama at Birmingham. She received her Ph.D in Genetics at Iowa State University in 2001 and a three-year postdoctoral training in statistical genetics at the Jackson Laboratory afterwards. Her research is on experimental design and data analyses of high-throughput experiments including microarray, next-generation sequencing, statistical genetics/genomics, epigenomics.